Association between Mild Behavioral Impairment trajectories and AD biomarkers in adults with Mild Cognitive Impairment. Results from the CompAS study

  1. Mallo, Sabela Carme 1
  2. Fernández, Miguel Ángel Rivas 2
  3. Vázquez‐Vázquez, Laura 4
  4. Galdo‐Álvarez, Santiago 2
  5. Lindín, Mónica 2
  6. Nieto‐Vieites, Ana 1
  7. Juncos‐Rabadán, Onésimo 1
  8. Aldrey, Jose M. 3
  9. Díaz, Fernando 2
  10. Ismail, Zahinoor 5
  11. Pereiro, Arturo X 1
  1. 1 University of Santiago de Compostela, Santiago de Compostela Spain
  2. 2 Universidade de Santiago de Compostela, Santiago de Compostela Spain
  3. 3 University Hospital of Santiago de Compostela, Santiago de Compostela Spain
  4. 4 Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela Spain
  5. 5 Hotchkiss Brain Institute, University of Calgary, Calgary, AB Canada
Zugehörigkeit anzeigen +
Zeitschrift:
Alzheimer's & Dementia

ISSN: 1552-5260,  1552-5279

Datum der Publikation: 2023

Ausgabe: 19

Nummer: S14

Art: Artikel

DOI: 10.1002/ALZ.074148 GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Alzheimer's & Dementia

Ziele für nachhaltige Entwicklung

Zusammenfassung

BackgroundOur aim was to investigate the association of the NPS trajectories in time measured by MBI-C for MCI patients with the CSF biomarkers and temporal lobe atrophy detected at baseline.MethodCSF biomarkers at baseline were obtained from 71 patients with MCI belonging to Compostela Aging Study (CompAS) (Spain). Positivity for A (β-amyloid), T (p-Tau), and N (t-Tau) was defined by cut-off levels. Structural MRI was employed to evaluate cortical thickness and volume. Mild behavioral impairment was assessed using the validated Spanish-language MBI-C (Mallo et al., 2018) at baseline, 24 months, and 60 months follow-up. Spearman correlations were performed to evaluate the relationships between CSF biomarkers at baseline and MBI-C scores for the three evaluations. Logistic regressions were used to test the predictive value of the MBI-C scores at each evaluation on the biomarkers’ positivity at baseline, and linear regression analyses to test the relationships between cortical thickness and volume at baseline and the three MBI-C scorings.ResultsSpearman correlations showed no significant relations between MBI-C and β-amyloid, pTau, tTau and tTau/β-amyloid ratio at baseline. However, significant positive correlations appeared between MBI-C at 24-month follow-up and pTau (rho = .371), tTau (rho = .282) and tTau/β-amyloid ratio at baseline but not with β-amyloid. MBI-C scores at the 60-month follow-up only significantly correlated with tTau/β-amyloid ratio (rho = -.418). MBI-C at 24 months and at 60 months were respectively predicted by pTau and tTau (Table 1). Linear regression analyses showed that MBI-C at 24 months was predicted by cortical thickness of entorhinal, fusiform, inferior temporal, inferior parietal, middle and supramarginal gyri. MBI-C at 24 and 60 months were predicted by Volume of entorhinal, inferior temporal, precuneus and whole hippocampus (Table 2).ConclusionThe markers of atrophy in structures of the medial temporal lobe and the lateral and parietal temporal lobe, and pTau+ or tTau+ in MCI patients at baseline were associated with worsening of neuropsychiatric symptoms at 24 and/or 60 months